Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cost consequences of the 340B drug discount program.

Literature DB >> 23609758

Cost consequences of the 340B drug discount program.

Rena M Conti¹, Peter B Bach.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：
Antineoplastic Agents

Year: 2013 PMID： 23609758 PMCID： PMC4036617 DOI： 10.1001/jama.2013.4156

Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272

× No keyword cloud information.

3 in total

1. Finance. New Medicare cuts will force hospitals to plug major revenue leak.

Authors: Mark Taylor
Journal: Hosp Health Netw Date: 2010-09

2. Strategic integration of hospitals and physicians.

Authors: Alison Evans Cuellar; Paul J Gertler
Journal: J Health Econ Date: 2005-11-23 Impact factor: 3.883

3. How Medicare's payment cuts for cancer chemotherapy drugs changed patterns of treatment.

Authors: Mireille Jacobson; Craig C Earle; Mary Price; Joseph P Newhouse
Journal: Health Aff (Millwood) Date: 2010-06-17 Impact factor: 6.301

3 in total

16 in total

1. The 340B discount program: outpatient prescription dispensing patterns through contract pharmacies in 2012.

Authors: Bobby L Clark; John Hou; Chia-Hung Chou; Elbert S Huang; Rena Conti
Journal: Health Aff (Millwood) Date: 2014-11 Impact factor: 6.301

2. Improving outpatient oncology practice: several steps into a long journey.

Authors: Rena M Conti; Peter B Bach
Journal: J Oncol Pract Date: 2014-10-14 Impact factor: 3.840

3. Payment for oncolytics in the United States: a history of buy and bill and proposals for reform.

Authors: Blase N Polite; Jeffery C Ward; John V Cox; Roscoe F Morton; John Hennessy; Ray D Page; Rena M Conti
Journal: J Oncol Pract Date: 2014-11 Impact factor: 3.840

4. Value-Based Physician Payment in Oncology: Public and Private Insurer Initiatives.

Authors: James C Robinson
Journal: Milbank Q Date: 2017-03 Impact factor: 4.911

5. Medical Group Characteristics and the Cost and Quality of Care for Medicare Beneficiaries.

Authors: Lawrence P Casalino; Patricia Ramsay; Laurence C Baker; Michael F Pesko; Stephen M Shortell
Journal: Health Serv Res Date: 2018-07-05 Impact factor: 3.402

6. Diffusion of Bevacizumab Across Oncology Practices: An Observational Study.

Authors: Nancy L Keating; Haiden A Huskamp; Deborah Schrag; John M McWilliams; Barbara J McNeil; Bruce E Landon; Michael E Chernew; Sharon-Lise T Normand
Journal: Med Care Date: 2018-01 Impact factor: 2.983

7. Reform of the Buy-and-Bill System for Outpatient Chemotherapy Care Is Inevitable: Perspectives from an Economist, a Realpolitik, and an Oncologist.

Authors: Blase Polite; Rena M Conti; Jeffery C Ward
Journal: Am Soc Clin Oncol Educ Book Date: 2015